What is Growth Strategy and Future Prospects of Making Science Company?

What is the Growth Strategy and Future Prospects of Making Science Company?

Making Science, a digital acceleration firm, has strategically positioned itself in the evolving digital marketing and technology solutions sector. Its expansion into international markets in 2020, following its public listing, signaled a key change in its direction.

Founded in 2016, the company aimed to offer integrated technology and marketing solutions, emphasizing digital transformation through cloud computing, data analytics, digital advertising, and e-commerce. Its objective is to boost clients' online performance using data-driven strategies and innovation.

The company's growth has been substantial, evolving from a focus on Spain and Portugal to becoming an international digital acceleration entity. With over 1,200 experts across 22 offices in 15 countries, it addresses client needs via digital marketing, AdTech & MarTech, and Cloud Technology & Software. This global presence, combined with local market insights, highlights its significant role in digital transformation. The ongoing need for digital transformation and advancements in AI, like those analyzed in the Making Science BCG Matrix, suggest continued relevance and growth opportunities.

The growth strategy for this science company is built on a dual focus: expanding its geographical footprint and diversifying its product and service portfolio. This approach is guided by a long-term vision, 'Plan 2027', aiming for sustained development and market leadership.

International Expansion

The company is actively pursuing international expansion, with a significant focus on the USA market. Following the acquisition of a Google Marketing Platform Reselling contract in January 2024, the US customer base has grown substantially, achieving break-even in Q4 2024 and maintaining it through Q1 2025.

Revenue Growth in Key Markets

In Q1 2025, international revenues reached €48 million, surpassing Spain's €32 million and accounting for 60% of Core Business Revenues. This growth is also evident in other regions like France and the Nordics, indicating a successful global market penetration strategy.

Strategic Mergers and Acquisitions

The company continues to leverage mergers and acquisitions to fuel its growth. An agreement in June 2024 to acquire the remaining 24% stake in United Communications Partners Inc. (UCP) aims to consolidate ownership and operational efficiency. These inorganic growth strategies, often financed through bond issuances, are designed to attract new clients and diversify revenue streams.

Product and Service Diversification with AI Focus

Expansion of product and service offerings is a critical component, particularly in Artificial Intelligence (AI). The introduction of RAISING in January 2025, a new AI technology division, integrates business acumen with data science to create advanced AI solutions.

AI-Driven Solutions

This new AI division encompasses technological tools such as ad-machina, Gauss AI, and Trust Generative AI. These offerings provide innovative methods for measuring and optimizing marketing strategies, crucial for adapting to industry shifts and meeting the demands of businesses undergoing digital transformation. This aligns with the broader Marketing Strategy of Making Science.

• Development of advanced AI-based solutions
• Tools for marketing strategy optimization
• Focus on data science integration
• Addressing evolving needs of digitally transforming businesses

The company's growth strategy science company approach is deeply rooted in technological innovation and the development of proprietary platforms. This focus on in-house expertise, particularly in software engineering, data engineering, and data science, underpins its ability to create advanced digital solutions.

AI-Powered Marketing Division

The establishment of RAISING in January 2025 signifies a dedicated push into AI for marketing. This division merges business acumen with data science to deliver sophisticated AI solutions.

Key AI Technologies

RAISING incorporates tools like ad-machina, Gauss AI, and Trust Generative AI. Trust Generative AI, for example, is designed for scalable, SEO-friendly content creation using proprietary data.

BrandMax Success Metrics

BrandMax, part of the Gauss AI suite, demonstrated significant improvements in branding campaigns. Trials with a major hotel chain showed an 83% increase in impressions and a 50% rise in Average Viewable Time.

Digital Transformation Focus

The company emphasizes end-to-end capabilities in digital transformation and cloud computing. This includes consulting, development, integration, and maintenance of advanced IT solutions.

DevOps as a Growth Driver

The company's strategy highlights 'DevOps as a Growth Strategy,' focusing on operational speed, security, and scalability. This approach also addresses critical data protection measures for 2025.

Commitment to R&D

While specific R&D investment figures are not public, the consistent introduction of new AI-driven tools and platforms, supported by a large team of specialized engineers, indicates a strong commitment to technological advancement.

Technological Foundation for Growth

The science company growth is intrinsically linked to its technological prowess. By developing proprietary platforms and integrating advanced AI, the company aims to offer unique solutions that drive client success and its own expansion. This focus on innovation is a core element of its overall Growth Strategy of Making Science.

• Proprietary platform development
• AI integration for marketing and operations
• In-house expertise in data science and engineering
• Focus on scalable and secure content generation
• Commitment to digital transformation and cloud solutions
• Emphasis on DevOps for operational efficiency

The company has established a significant presence across multiple geographies, with a particular focus on expanding its operations in the USA. This strategic expansion is a key component of its overall growth strategy.

Q1 2025 Revenue Growth

The company reported consolidated Q1 2025 revenues of €82.7 million. This represents a substantial 33% increase compared to €62.4 million in Q1 2024.

Gross Margin and EBITDA Performance

Gross margin saw a 5% rise to €18.5 million. Recurring EBITDA reached a record high of €4.0 million, an 11% increase year-over-year.

Core Business and USA Operations

The core business, excluding investments, experienced a 35% revenue increase to €80.2 million. USA operations achieved profitability, reaching break-even in Q4 2024 and maintaining it in Q1 2025.

Full Year 2025 Guidance

The company has provided guidance for the full year 2025, projecting revenues of €350-370 million. Recurring EBITDA is expected to be between €17-18 million.

The financial trajectory indicates a strong emphasis on profitability and sustainable growth, aligning with the broader science company growth strategy. The company has already achieved approximately 23% of its annual EBITDA target in the first quarter of 2025. Looking ahead to 2027, the 'Plan 2027' targets recurring EBITDA of €23-27 million, suggesting a compound annual growth rate of 20% from 2025 to 2027. This financial outlook supports the company's ambition for significant expansion and market leadership, reflecting a well-defined science business development approach. As of July 21, 2025, the company's stock was trading at $10.58, with a market capitalization of $93.9 million, providing a clear indicator of investor confidence in its growth strategy.

Revenue Growth Drivers

Key growth drivers include the expansion of USA operations and the robust performance of the core business, demonstrating effective strategies for scaling a research and development company.

Profitability Focus

The financial strategy prioritizes profitability and cash flow generation, alongside debt reduction, which are crucial for long-term sustainability in the science sector.

Long-Term Targets

The 'Plan 2027' sets ambitious recurring EBITDA targets, indicating a clear roadmap for future expansion and a commitment to achieving significant growth in the coming years.

Market Valuation

The current market capitalization of $93.9 million reflects market sentiment and the perceived value of the company's growth strategy and future prospects.

USA Market Penetration

Achieving sustainable profitability in the USA market is a significant milestone, validating the company's expansion strategy and its potential for further penetration.

Financial Health

The focus on debt reduction alongside growth demonstrates a balanced approach to financial management, essential for science company expansion and long-term viability.

Financial Outlook Summary

The company's financial performance in Q1 2025 shows robust growth across key metrics, with strong guidance for the full year 2025 and ambitious targets for 2027. This indicates a well-executed growth strategy for the science company.

• Consolidated Q1 2025 revenue: €82.7 million (up 33% YoY)
• Gross margin: €18.5 million (up 5% YoY)
• Recurring EBITDA: €4.0 million (up 11% YoY)
• Full Year 2025 Revenue Guidance: €350-370 million
• Plan 2027 Recurring EBITDA Target: €23-27 million (20% CAGR)
• Market Capitalization (July 21, 2025): $93.9 million
• Stock Price (July 21, 2025): $10.58

While the company shows strong growth, it faces significant hurdles. Intense market competition in digital marketing and technology consulting, coupled with declining industry growth rates since 2022, presents a challenging environment for its science company growth strategy.

Intense Market Competition

The digital marketing and technology consulting sectors are highly competitive. Many firms are vying for digital transformation projects, making it crucial for the company to maintain its edge.

Slowing Industry Growth

Industry growth rates have been on a downward trend since 2022. This indicates a more challenging market landscape for science company expansion.

Technological Disruption

Rapid advancements, particularly in Artificial Intelligence (AI), pose both opportunities and risks. Continuous, significant R&D investment is necessary to stay competitive.

Regulatory Changes

Evolving data protection and privacy regulations across 15 international markets require constant vigilance and investment in compliance. This is a key consideration for a science business development approach.

Talent Acquisition Challenges

Attracting and retaining top-tier tech talent, especially in fields like machine learning and big data, remains a significant hurdle due to high market demand.

AI's Impact on Workforce

The potential impact of AI on the job market could affect the availability and cost of skilled data science professionals, influencing the science company growth.

To navigate these challenges, the company is employing a multi-faceted strategy. Diversification across geographical markets and service offerings, including digital marketing, AdTech & MarTech, and Cloud Technology & Software, is a key risk mitigation tactic. The focus on operational efficiency and profitability, as detailed in their 'Plan 2027,' aims to build financial resilience against market volatility. Furthermore, strategic partnerships and ongoing investment in proprietary technology are crucial for addressing rapid technological shifts and maintaining a competitive advantage in the science company growth landscape.

Diversification Strategy

The company mitigates risks through a broad geographical presence and diverse service portfolio, covering digital marketing, AdTech & MarTech, and Cloud Technology & Software.

Operational Efficiency Focus

Emphasis on operational efficiency and profitability, as outlined in 'Plan 2027,' enhances financial resilience against market fluctuations, supporting the science company growth.

Strategic Partnerships & Technology Investment

Collaborations and continuous investment in proprietary technology are vital for staying ahead of rapid technological shifts and intense market competition, crucial for the science company strategy.

Adapting to AI Advancements

Active investment in AI through its RAISING division and proprietary tools demonstrates a commitment to leveraging new technologies, aligning with future trends in science company business models.